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Streptococcus pneumoniae is a major pathogen that causes various diseases, including pneumonia and
sepsis, as millions of people suffer from S. pneumoniae infection worldwide. To better understand the
immune and inflammatory responses to S. pneumoniae, we produced murine models. To investigate the
differences between intranasal and intratracheal infection, BALB/c mice were infected with S. pneumoniae
D39 intranasally or intratracheally. Mice showed no significant differences in survival rates, body weight
changes, and bacterial loads. To investigate resistance and susceptibility among mouse strains, BALB/c,
C57BL/6J, tumor necrosis factor-α (TNF-α) knockout, and interleukin-10 (IL-10) knockout mice were
infected with S. pneumoniae D39 via intranasal or intravenous routes. In this study, BALB/c and C57BL/6J
mice were resistant, IL-10 knockout mice were intermediate, and TNF-α knokout mice were susceptible to
S. pneumoniae infection. These data show that intranasal and intratracheal infection induced similar
results after S. pneumoniae infection, and the genetic background of mice must be considered when
studying S. pneumoniae infection in vivo.
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Streptococcus (S) pneumoniae, a pneumococcus, is an
important pathogen that causes various infectious diseases,
such as pneumonia, septicemia, meningitis, sinusitis, and otitis
media [1]. Pneumococcal pneumonia is especially common
among children and elderly people, who have weak immunity.
Despite the availability of excellent antibiotics therapy, S.
pneumoniae continues to induce considerable morbidity and
mortality worldwide. For instance, it has been reported that
about 800,000 children younger than 5 years old die due
to S. pneumoniae infection worldwide each year, and 90%
of cases occur in developing countries [2]. Two major problems
in the control of S. pneumoniae diseases are increased
antibiotic resistance and restricted efficacy of the vaccine [3,4].
During the past three decades, antimicrobial resistance to
S. pneumoniae has severely increased, with rapid spreading
of antibiotic-resistant S. pneumoniae having been observed
in Southern and Eastern Europe, North America, South
America, Africa, and Asia [5]. Several vaccines are used for
the prevention of S. pneumoniae infection, but there still are
limitations. The most commonly used 23-valent polysaccharide
vaccine is effective against only 23 out of 90 serotypes and
does not confer a protective effect in children younger than
2 years of age or in elderly people [6]. A 7-valent pneumococcal
conjugate vaccine, which is effective in children, has also
been available since 2000, but it is expensive and protects
only against seven serotypes [6].
Despite the importance of S. pneumoniae as a major human
pathogen, interactions between host and pathogen are not
understood clearly. Therefore, study of the virulence factors
of  S. pneumoniae as well as the host immune defense
mechanisms against S. pneumoniae infection in an animal
model is required to better understand and control this disease.
Recently, it was shown that susceptibility and resistance to
S. pneumoniae differ among mouse strains [7,8]. Furthermore,
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the effect of pneumolysin, a virulence factor of S. pneumoniae,
is dependent on the genetic background of the mice [9].
During bacterial infection, the immune and inflammatory
responses are characterized by complex and dynamic processed
that are associated with the expression of both pro- and
anti-inflammatory cytokines and chemokines [10]. tumor
necrosis factor-α (TNF-α) is a pro-inflammatory cytokine that
activates immune and inflammatory responses. TNF-α has
helpful [11] as well as damaging effects [12] on the host
response to infection. Interleukin-10 (IL-10) is an anti-
inflammatory cytokine that down-regulates pro-inflammatory
cytokines such as TNF-α and interferin-γ (IFN-γ). During S.
pneumoniae-induced pneumonia, IL-10 attenuates the pro-
inflammatory cytokine response in the lungs, hampers effective
clearance of infection, and shortens survival [13].
To compare the differences between intranasal (IN) and
intratracheal (IT) infection with S. pneumoniae, we infected
BALB/c mice intranasally or intratracheally. To investigate the
susceptibility and resistance of mouse strains as well as the
role of TNF-α and IL-10 in response to S. pneumoniae infection,
we produced a murine model of pneumococcal disease using
four mouse strains: BALB/c, C57BL/6J, TNF-α knockout (KO),
and IL-10 KO mice. We infected mice with different numbers
of S. pneumoniae by IN or intravenous (IV) routes, and observed
the survival rates and body weight changes.
Materials and Methods
Animals
Male and female BALB/c, C57BL/6J, TNF-α KO (B6.129S-
Tnf
tm1Gkl/J), and IL-10 KO (B6.129P2-Il10
tm1Cgn/J) mice 7 to
8 weeks old were used in this study. BALB/c and C57BL/
6J mice were purchased from Korea Research Institute of
Bioscience and Biotechnology (KRIBB, Daejeon, Korea). TNF-
α KO and IL-10 KO mice were purchased from Jackson
Laboratory (Bar Harbor, Maine, USA). Animals were maintained
in a specific pathogen free barrier facility at the College of
Veterinary Medicine at Konkuk University (Seoul, Korea).
Animals were allowed free access to sterilized food and water.
Animal room was maintained in a 12 hour light-dark cycle,
and the room temperature was maintained at 22±2
oC with
50±10% relative humidity. This study was approved by the
Institutional Animal Care and Use Committee (IACUC) of
Konkuk University.
Bacterial preparation
S. pneumoniae D39 serotype 2 was obtained from The
Korea Centers for Disease Control and Prevention (KCDC,
Osong, Korea). Bacteria were cultured on a 5% sheep blood
agar plate at 37
oC and 5% CO2 for 18 hours. Bacteria were
harvested, rinsed, and resuspended with sterilized phosphate
buffered saline (PBS) and then transferred to brain-heart
infusion (Merck, Darmstadt, Germany) broth, followed by
culture at 37
oC and 5% CO2 for 6 hours. Bacteria were pelleted
by centrifugation, washed, and resuspended with sterilized
PBS. Bacterial concentrations were estimated by measuring
the absorbance value at an optical density of 600 nm using
a spectrophotometer. Colony forming units (CFU)/mL were
counted by plating the serially diluted bacterial suspension.
Infection
Mice were anesthetized by intraperitoneal administration
of 40 mg/kg of Zoletil
TM (Virbac Laboratories, Carros, France)
and 5 mg/kg of Rompun
TM (Bayer Korea, Anseong, Korea).
To compare the differences between IN and IT infection,
20 µL of the S. pneumoniae suspension containing 2×10
7
CFU was inoculated in male BALB/c mice via the nostril
(IN) or trachea (IT). Briefly, a small incision was made to
expose the trachea, and the bacterial suspension was injected
intratracheally using a 31-gauge needle. The incision was
closed using surgical staples.
To compare the resistance to pneumococcal disease among
the infection routes and infectious doses, 2×10
2 to
 2×10
4
and 2×10
6 to 2×10
8 CFU of bacterial suspensions were
infected into BALB/c, C57BL/6J, TNF-α KO and IL-10 KO
mice via the lateral tail vein and nostril, respectively. Male
mice were used for the intranasal infection study while female
mice were used for the intravenous infection study. After
infection, survival and body weight of the mice were measured
every 24 hours for 10 days.
CFU analysis
After anesthetization by peritoneal infection of 40 mg/kg
of Zoletil
TM (Virbac Laboratories) and 5 mg/kg of Rompun
TM
(Bayer Korea), blood was collected from the axillary vessels.
Exactly 20 µL of blood was diluted serially and used for CFU
analysis. The nasopharynx and lung were then removed from
each mouse, followed by homogenization by a tissue
homogenizer in sterile PBS and serial dilution. Diluted blood
and homogenates were cultured on 5% sheep blood agar
plates at 37
oC and under 5% CO2 atmosphere for 24 hours,
after which CFU were counted.
Statistical analysis
Body weight changes and bacterial counts are expressed
as mean±SD. Significant differences between the groups were
evaluated using unpaired Student’s t-test. Survival rates were
compared by a log-rank test. Data analysis was performedResistance to S. pneumoniae 93
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by Prism 5 for Windows (Graphpad Software Inc.). P<0.05
was considered to be statistically significant.
Results
Comparing intranasal infection with intratracheal
infection
To compare IN and IT infection, we measured survival
rate and changes in body weight after infection with 2×10
7
CFU of S. pneumoniae D39 (Figure 1). Mice infected by
IN administration began to die at 3 days after infection, whereas
mice infected by IT administration began to die at 2 days
after infection. At 5 days after infection, the survival rates
of mice infected intranasally and intratracheally were 60%
and 50%, respectively. IT infection resulted in a 10% higher
mortality rate compared to IN infection, but no significant
difference was observed between the two groups. The body
weights of the mice infected intranasally and intratracheally
decreased until 4 days after infection and began to increase
from 5 days after infection. In the early and late phases of
infection, body weight changes were significantly different
(P<0.05) between the two groups. Additionally, at 12 hours
after infection, both the IN and IT groups demonstrated
increased bacterial numbers in the nasopharynx, lung, and
blood. Specifically, bacterial numbers in the blood of
intranasally infected mice were significantly (P<0.05) lower
than those in the blood of intratracheally infected mice at
this time. At 36 hours after infection, bacterial numbers in
the lung of intranasally infected mice were significantly
(P<0.05) higher than those of in the lung of intratracheally
infected mice. Based on these observations, there were no
significant differences between IN and IT infection (Figure 2).
Comparing the bacterial resistance of intranasally
infected mice by infectious dose
To compare bacterial resistance by infectious dose, BALB/
c, C57BL6/J, TNF-α KO, and IL-10 KO mice were infected
intranasally with S. pneumoniae D39. The results show marked
differences in survival rates and body weight changes among
the mouse strains (Figure 3). After infection with 2×10
6 CFU
of S. pneumoniae D39, BALB/c and C57BL/6J mice showed
high resistance. The survival rate was 87.5% in both the BALB/
c and C57BL/6J strains. One BALB/c mouse died at 4 days
after infection, but the remaining seven mice survived until
10 days after infection, at which time the experiment was
ended. In BALB/c mice, no body weight changes were
observed for 4 days after infection, but increases occurred
from 5 days after infection. One C57BL/6J mouse died at
5 days after infection, and no more dead mice were observed
during the experiment. No difference in the survival rate was
observed between BALB/c and C57BL/6J mice. C57BL/6J mice
underwent slight body weight gains from 6 days after infection.
TNF-α K O  m i c e  w e r e  s u s c e p t i b l e  t o  S. pneumoniae D39
infection. One TNF-α KO mouse began to die at 3 days
after infection, and 62.5% of the mice died at 4 days after
infection. The remaining 25% mice died gradually until 7
days after infection. TNF-α KO mice showed significantly
(P<0.01) lower survival rate than the other three mouse strains.
IL-10 KO mice began to die at 4 days after infection, and
50% of the IL-10 KO mice survived until the end of the
experiment. Body weights of TNF-α KO and IL-10 KO mice
decreased after infection, and both TNF-α KO and IL-10
KO mice did not recover their body weight.
Mice infected intranasally with 2×10
7 CFU of S. pneumoniae
D39 began to die earlier than mice infected with 2×10
6 CFU
of S. pneumoniae D39. One IL-10 KO mouse began to die
at 1 day after infection, whereas TNF-α KO mice began to
die at 2 days after infection. Surprisingly, all of the remaining
TNF-α KO mice died at 3 days after infection. At the end
of the experiment, all of the C57BL/6J mice, 75% of the
BALB/c, and 75% of the IL-10 KO mice survived. TNF-α
KO mice showed a significantly (P<0.01) lower survival rate
compared to the other mouse strains. Body weights of the
infected mice decreased during early phase of infection, after
Figure 1. Survival rates (A) and body weight changes (B) of BALB/c mice infected with 2×10
7 CFU of S. pneumoniae D39 serotype
2 via intranasal (IN) and intratracheal (IT) routes. Data are means±SD. *P<0.05 versus IT infection at each time point.94 Dong-Gu Jeong et al.
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which they began to increase continuously except in TNF-
α KO mice. TNF-α KO mice showed continuous body weight
loss after infection.
Mice infected intranasally with 2×10
8 CFU of S. pneumoniae
D39 experienced the most severe lethality and body weight
losses. Interestingly, 75% of the BALB/c mice began to die
at 1 day after infection, whereas the remaining 25% died
at 2 days after infection. On the other hand, BALB/c mice
showed high resistance to 10
6 and 10
7 CFU of S. pneumoniae
D39 infection. Regarding TNF-α KO mice, 75% began to
die at 2 days after infection, whereas the remaining 25%
died at 3 days after infection. C57BL/6J and IL-10 KO mice
also began to die at 2 days after infection, whereas 25%
of the C57BL/6J mice and 50% of the IL-10 KO mice survived
until the end of the experiment. TNF-α KO and BALB/c mice
showed a significantly (P<0.05) lower survival rate compared
to the C57BL/6J and IL-10 KO mice. The BALB/c, C57BL/
6J, and TNF-α KO mice experienced continuous losses in
body weight, but the IL-10 KO mice recovered.
Comparing the bacterial resistance of intravenously
infected mice by infectious dose
To compare bacterial resistance by infectious dose, BALB/
c, C57BL6/J, TNF-α KO, and IL-10 KO mice were infected
intravenously with S. pneumoniae D39. The results show
marked differences in survival rates and body weight changes
among the mouse strains (Figure 4). BALB/c and C57BL6/
J mice were resistant to S. pneumoniae D39 infection. After
infection with 2×10
2 CFU of S. pneumoniae D39, one BALB/
c mouse began to die at 2 days after infection, whereas
the remaining mice survived until the end of the experiment.
All of the C57BL/6J mice survived until the end of the
experiment. Exactly 37.5% of the TNF-α KO mice began
to die at 2 days after infection, whereas 50% died at 3 days
after infection. One IL-10 KO mouse began to die at 3 days
after infection, and 75% mice survived until the end of the
experiment. TNF-α KO mice showed a significantly lower
survival rate compared to the other three mouse strains
(P<0.01). The body weights of the BALB/c, C57BL/6J, and
IL-10 KO mice slightly increased, whereas that of TNF-α KO
mice decreased after infection. Body weight of BALB/c mice
increased continuously after infection.
After mice were infected intravenously with 2×10
3 CFU
of S. pneumoniae D39, exactly 87.5% of the BALB/c mice
and all of the C57BL/6J mice survived until the end of the
experiment. Both the IL-10 KO and TNF-α KO mice began
to die at 2 days after infection. All of the TNF-α KO and
62.5% of the IL-10 KO mice died within 3 days after infection.
The remaining 37.5% IL-10 KO mice survived until the end
of the experiment. TNF-α KO mice showed a significantly
Figure 2. Bacterial numbers in the nasopharynx (A), lung (B), and blood (C) of BALB/c mice infected with 2×10
7 CFU of S.
pneumoniae D39 serotype 2 via intranasal (IN) and intratracheal (IT) routes. Data are means±SD. *P<0.05 versus IN or IT infection
at each time point.Resistance to S. pneumoniae 95
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(P<0.01) lower survival rate compared to the BALB/c and
C57BL/6J mice, whereas the IL-10 KO mice showed a
significantly (P<0.05) lower survival rate compared to the
C57BL/6J mice. The body weights of the BALB/c and C57BL/
6J mice slightly increased, whereas those of the TNF-α KO
and IL-10 KO mice decreased after infection.
After mice infected intravenously with 2×10
4 CFU of S.
pneumoniae D39, surprisingly, 75% of the TNF-α KO mice
died at 2 days after infection, whereas the remaining 25%
died at 3 days after infection. The IL-10 mice began to die
at 2 days after infection, and the remaining 87.5% died within
4 days after infection. Exactly 50% of the BALB/c mice died
within 3 days after infection, and 62.5% of the C57BL/6J
mice died within 4 days. TNF-α KO mice showed a significantly
(P<0.05) lower survival rate compared to the BALB/c and
C57BL/6J mice. Body weight of the BALB/c mice decreased
after infection and recovered, whereas those of the C57BL/
6J, TNF-α KO, and IL-10 mice decreased after infection.
Discussion
Currently, interactions between the host and S. pneumoniae
are not understood clearly. To better understand the host
defense mechanism against S. pneumoniae infection, we
produced a S. pneumoniae disease mouse model using BALB/
c, C57BL/6J, TNF-α KO, and IL-10 KO mouse strains. Various
CFU of S. pneumoniae D39 serotype 2 were inoculated by
IN, IT, and IV routes, and survival rates and body weight
changes were monitored. Each strain demonstrated a distinct
immune response and showed a different survival rate and
body weight after S. pneumoniae infection. This study
compared IN and IT infection between resistant and
susceptible mouse strains and explored the roles of TNF-α
and IL-10 during S. pneumoniae D39 infection.
IT infection in BALB/c mice resulted in a higher rate of
mortality, more rapid death, and more body weight loss
compared to IN infection, but no significant differences were
Figure 3. Survival rates (A, C, and E) and body weight changes (B, D, and F) of BALB/c, C57BL6J, IL-10 knockout, and TNF-α
knockout mice. Mice were infected with 2×10
6 (A and B),
 2×10
7 (C and D) and 2×10
8 (E and F) CFU of S. pneumoniae D39 serotype
2 via intranasal route. Data are means±SD.96 Dong-Gu Jeong et al.
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observed between the two groups. These findings suggest
that noninvasive IN infection induced similar results compared
to IT infection. The advantages of IT infection are the perfect
delivery of the bacterial inoculums and development of
pneumonia, but IT infection requires practice and invasive
surgical procedures for induction of disease [14]. On the other
hand, IN infection is easy and fast to carry out without complex
and invasive surgical techniques and mimics the natural route
of infection [6]. For these reasons, IN infection is the most
commonly used method. In this study, similar CFU in the
nasopharynx, blood, and lung were observed in both infection
models. Thus, we used the noninvasive IN method for the
next experiment.
If BALB/c, C57BL/6J, TNF-α KO, and IL-10 KO mice are
divided into resistant, intermediate, and susceptible strains
based on their survival rates in this study, BALB/c and C57BL/
6J mice were the resistant strains, IL-10 KO mouse was the
intermediate strain, and TNF-α KO mouse was the susceptible
strain. The most resistant strain was the C57BL/6J mice while
the second most resistant strain was BALB/c mice, but a
significant difference between the survival rates of the BALB/
c and C57BL/6J mice was not observed using both infection
routes with 2×10
6 or 2×10
7 CFU of S. pneumoniae D39.
However, when BALB/c mice were infected intranasally with
2×10
8 CFU of S. pneumoniae D39, interestingly, the survival
rate of BALB/c mice was significantly lower than those of
C57BL/6J and IL-10 KO mice. However, in a previous study,
BALB/c mice were resistant and C57BL/6 mice were intermediate
to S. pneumoniae D39 infection [7], even though the infectious
dose of was lower than that of our experiment. Another
previous study reported that a significant difference in the
survival rate did not occur between the BALB/c and C57BL/
6J mice infected with 5×10
7 CFU of S. pneumoniae WU2
[8]. Based on previous and our studies, the differences in
susceptibility between the mouse strains may be dependent
on the infectious dose and the bacterial strain.
Figure 4. Survival rates (A, C, and E) and body weight changes (B, D, and F) of BALB/c, C57BL6J, IL-10 knockout, and TNF-α
knockout mice. Mice were infected with 2×10
2 (A and B),
 2×10
3 (C and D) and 2×10
4 (E and F) CFU of S. pneumoniae D39 serotype
2 via intravenous route. Data are means±SD.Resistance to S. pneumoniae 97
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TNF-α has been reported to play important roles in bacterial
clearance and survival in response to S. pneumoniae infection
[15-18]. Administration of anti-TNF-α monoclonal antibody
leads to impaired recruitment of neutrophils, impaired bacterial
clearance, and accelerated death after infection with S.
pneumoniae [19]. In this study, TNF-α KO mice showed the
most susceptibility to S. pneumoniae D39 infection. All of
the TNF-α KO mice infected with S. pneumoniae D39 died
before 9 days after infection. This may have been due to
impaired bacterial clearance due to the lack of TNF-α. The
time between infection and death in our study quickly
decreased as the infectious dose of S. pneumoniae D39 was
increased.
IL-10 acts as an important regulator of the immune response
by limiting the inflammatory response and protecting the host
from tissue damage caused by excessive inflammation [20].
This prevention is based on the down-regulation of the
production of pro-inflammatory cytokines and chemokines
and the reduction of the expression of adhesion molecules
of S. pneumoniae [21]. In the case of intranasal infection,
interestingly, the survival rates of IL-10 KO mice did not
decrease as the infectious dose of S. pneumoniae D39 was
increased. The survival rates of IL-10 KO mice after IN infection
with 10
6, 10
7, and 10
8 CFU of S. pneumoniae D39 were
50, 75, and 50%, respectively. Furthermore, IL-10 KO mice
showed the highest survival rate among the mice infected
intranasally with 10
8 CFU of S. pneumoniae D39. This may
have resulted from the enhanced inflammatory response of
IL-10 KO mice due to increased pro-inflammatory cytokine
and chemokine production in response to a high dose of
S. pneumoniae. To conform this result, further research is
needed.
In summary, the genetic background of the mouse, serotype,
infectious dose of S. pneumoniae, infection route, and
production of cytokines associated with the immune response
have to be considered when studying the pathogenesis of
S. pneumoniae diseases in a murine model.
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